Frauke Goeman
Overview
Explore the profile of Frauke Goeman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
621
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Pascale V, Ganci F, Leone F, Manciocco V, Campo F, Mercurio A, et al.
Precis Clin Med
. 2025 Mar;
8(1):pbaf005.
PMID: 40083592
No abstract available.
2.
Canu V, Vaccarella S, Sacconi A, Pulito C, Goeman F, Pallocca M, et al.
Cell Death Dis
. 2024 Aug;
15(8):603.
PMID: 39164278
Triple negative breast cancer (TNBC) is an aggressive disease which currently has no effective therapeutic targets and prominent biomarkers. The Sperm Associated antigen 5 (SPAG5) is a mitotic spindle associated...
3.
Scalera S, Ricciuti B, Marinelli D, Mazzotta M, Cipriani L, Bon G, et al.
Clin Cancer Res
. 2024 Jul;
30(19):4397-4411.
PMID: 38980931
Purpose: Co-occurring mutations in KEAP1 and STK11/KRAS have emerged as determinants of survival outcomes in patients with non-small cell lung cancer (NSCLC) treated with immunotherapy. However, these mutational contexts identify...
4.
Corleone G, Sorino C, Caforio M, Di Giovenale S, De Nicola F, Goeman F, et al.
J Exp Clin Cancer Res
. 2024 Jun;
43(1):179.
PMID: 38926853
Background: Enhancer reprogramming plays a significant role in the heterogeneity of cancer. However, we have limited knowledge about the impact of chromatin remodeling in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL)...
5.
Iaiza A, Mazzanti G, Goeman F, Cesaro B, Cortile C, Corleone G, et al.
Cell Mol Life Sci
. 2024 Jun;
81(1):276.
PMID: 38909325
N-methyladenosine (mA) is one of the most prevalent and conserved RNA modifications. It controls several biological processes, including the biogenesis and function of circular RNAs (circRNAs), which are a class...
6.
The lncRNAMALAT1-WTAP axis: a novel layer of EMT regulation in hypoxic triple-negative breast cancer
Dragonetti M, Turco C, Benedetti A, Goeman F, Forcato M, Scalera S, et al.
Cell Death Discov
. 2024 Jun;
10(1):276.
PMID: 38862471
Early metastatic disease development is one characteristic that defines triple-negative breast cancer (TNBC) as the most aggressive breast cancer (BC) subtype. Numerous studies have identified long non-coding RNAs (lncRNA) as...
7.
Pulito C, Mori F, Sacconi A, Goeman F, Ferraiuolo M, Pasanisi P, et al.
Cell Discov
. 2024 Mar;
10(1):29.
PMID: 38480687
No abstract available.
8.
Di Modugno F, Di Carlo A, Spada S, Palermo B, DAmbrosio L, DAndrea D, et al.
EBioMedicine
. 2024 Feb;
101:105003.
PMID: 38340557
Background: Tertiary Lymphoid Structures (TLS) correlate with positive outcomes in patients with NSCLC and the efficacy of immune checkpoint blockade (ICB) in cancer. The actin regulatory protein hMENA undergoes tissue-specific...
9.
Palermo B, Franzese O, Frisullo G, DAmbrosio L, Panetta M, Campo G, et al.
J Exp Clin Cancer Res
. 2023 Oct;
42(1):287.
PMID: 37898752
Background: Immune checkpoint blockade (ICB) has significantly prolonged survival of non-small cell lung cancer (NSCLC) patients, although most patients develop mechanisms of resistance. Recently single-cell RNA-sequencing (scRNA-Seq) revealed a huge...
10.
Ronchetti L, Terrenato I, Ferretti M, Corrado G, Goeman F, Donzelli S, et al.
J Exp Clin Cancer Res
. 2023 Oct;
42(1):278.
PMID: 37875975
No abstract available.